Correlation Between FrontView REIT, and Telo Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FrontView REIT, and Telo Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FrontView REIT, and Telo Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FrontView REIT, and Telo Genomics Corp, you can compare the effects of market volatilities on FrontView REIT, and Telo Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FrontView REIT, with a short position of Telo Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of FrontView REIT, and Telo Genomics.

Diversification Opportunities for FrontView REIT, and Telo Genomics

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between FrontView and Telo is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding FrontView REIT, and Telo Genomics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telo Genomics Corp and FrontView REIT, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FrontView REIT, are associated (or correlated) with Telo Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telo Genomics Corp has no effect on the direction of FrontView REIT, i.e., FrontView REIT, and Telo Genomics go up and down completely randomly.

Pair Corralation between FrontView REIT, and Telo Genomics

Considering the 90-day investment horizon FrontView REIT, is expected to under-perform the Telo Genomics. But the stock apears to be less risky and, when comparing its historical volatility, FrontView REIT, is 10.01 times less risky than Telo Genomics. The stock trades about -0.03 of its potential returns per unit of risk. The Telo Genomics Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  10.00  in Telo Genomics Corp on September 20, 2024 and sell it today you would lose (2.00) from holding Telo Genomics Corp or give up 20.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy87.5%
ValuesDaily Returns

FrontView REIT,  vs.  Telo Genomics Corp

 Performance 
       Timeline  
FrontView REIT, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days FrontView REIT, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, FrontView REIT, is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Telo Genomics Corp 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Telo Genomics Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain technical and fundamental indicators, Telo Genomics reported solid returns over the last few months and may actually be approaching a breakup point.

FrontView REIT, and Telo Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FrontView REIT, and Telo Genomics

The main advantage of trading using opposite FrontView REIT, and Telo Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FrontView REIT, position performs unexpectedly, Telo Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telo Genomics will offset losses from the drop in Telo Genomics' long position.
The idea behind FrontView REIT, and Telo Genomics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stocks Directory
Find actively traded stocks across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum